Previous proteomics studies also reported a decrease in the abundance of Rbp4 in the CSF of patients with MS when compared with the clinically isolated syndrome [51], and with other neurological disorders (not validated) [17]. This evidence concerns the gene RBP4 and myeloid sarcoma.